GlassScriptPhysician profile
Robert H Ingham
NPI 1851358410
$2,612.96
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $452 · 2021: $686 · 2022: $978 · 2023: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $323 · Food and Beverage: $60.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $323.18 |
| Food and Beverage | $60.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $640.39 | 2019-2023 | Vumerity |
| Cadwell Industries, INC | $323.18 | 2023 | |
| Ucb, INC. | $269.11 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $140.58 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $124.44 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $103.00 | 2020 | |
| Celgene Corporation | $98.68 | 2021 | |
| Amgen INC. | $97.82 | 2019-2022 | |
| Mdd US Operations, LLC | $88.24 | 2022 | |
| Abbvie INC. | $87.30 | 2021-2022 | |
| Lilly USA, LLC | $85.26 | 2020-2021 | |
| Genzyme Corporation | $79.61 | 2019-2022 | |
| Bausch Health US, LLC | $69.37 | 2022-2023 | Aplenzin |
| Jazz Pharmaceuticals INC. | $58.75 | 2020 | |
| Livanova USA, INC. | $55.07 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $48.33 | 2022 | |
| Upsher-Smith Laboratories LLC | $47.42 | 2021 | |
| Eisai INC. | $39.04 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $37.99 | 2020-2021 | |
| Ge Healthcare | $29.45 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.22 | 2021 | |
| Impel Pharmaceuticals INC. | $22.80 | 2023 | Trudhesa |
| Kyowa Kirin, INC. | $22.64 | 2021 | |
| Banner Life Sciences, LLC | $20.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.